Justices Won't Review FTC's Impax Ruling
The U.S. Supreme Court has declined to take up Impax Laboratories' request to undo a Fifth Circuit decision upholding the Federal Trade Commission's finding that the drugmaker illegally delayed a generic...To view the full article, register now.
Already a subscriber? Click here to view full article